Typhidot IgM, IgG (Screening) at Ayzal Lab

Typhidot IgM, IgG (Screening) at Ayzal Lab

The Typhidot IgM, IgG (Screening) test at Ayzal Lab in Rawalpindi, Pakistan, is a rapid, highly specific, and sensitive serological assay designed for the qualitative detection of immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies against the Salmonella typhi bacterium. Salmonella typhi is the causative pathogen of typhoid fever (enteric fever), a systemic illness that remains a major public health concern in developing regions. Typhoid fever is primarily transmitted through the ingestion of food or water contaminated with the feces of infected individuals or chronic carriers. Early and accurate diagnosis is critical to initiating appropriate antimicrobial therapy, preventing severe systemic complications, and controlling the transmission of the disease within the community.

This screening test utilizes advanced immunochromatographic technology to identify specific outer membrane protein (OMP) antigens of Salmonella typhi. Unlike the traditional Widal test, which often yields cross-reactive false positives due to other non-typhoidal Salmonella species or baseline febrile illnesses, the Typhidot assay targets specific antigens that significantly enhance diagnostic specificity. The test is structured to differentiate between acute and past or convalescent infections by separately identifying IgM and IgG antibodies. IgM antibodies typically appear early in the course of the disease, usually within 2 to 3 days of onset of fever, indicating an acute, active infection. IgG antibodies develop later, representing past exposure, convalescence, or a secondary immune response. By evaluating both antibody classes, clinicians at Ayzal Lab can obtain a comprehensive immunological profile of the patient, enabling timely clinical decisions and targeted therapeutic interventions.

The clinical importance of the Typhidot IgM, IgG (Screening) test lies in its rapid turnaround time and high diagnostic accuracy during the early stages of enteric fever. While blood cultures remain the gold standard for diagnosing typhoid fever, they require specialized laboratory infrastructure, take 48 to 72 hours to yield results, and have a sensitivity that decreases significantly if the patient has already initiated antibiotic therapy. The Typhidot test overcomes these limitations by providing rapid results from a simple blood sample, even in patients who have already started treatment. This makes it an invaluable diagnostic tool for clinicians managing acute febrile illnesses in outpatient and inpatient settings across Rawalpindi.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the highest level of diagnostic accuracy and patient comfort, Ayzal Lab recommends the following preparation guidelines for the Typhidot IgM, IgG (Screening) test:

• No Fasting Required: Patients do not need to fast before this test. You may eat and drink normally prior to your visit.
• Medication Disclosure: Inform the laboratory staff and your prescribing physician about any medications you are currently taking, especially antibiotics, immunosuppressants, or corticosteroids, as these can potentially influence the immune response and antibody production.
• Hydration: Staying well-hydrated is highly recommended, as it makes the veins more accessible for venipuncture, facilitating a smoother and quicker sample collection process.
• Comfortable Clothing: Wear loose-fitting clothing or sleeves that can be easily rolled up above the elbow to allow clear access to the venipuncture site.

During the Procedure

The Typhidot IgM, IgG (Screening) test is a straightforward laboratory investigation involving a standard venipuncture (blood draw). The procedure is conducted by a qualified and experienced phlebotomist at Ayzal Lab, adhering to strict aseptic protocols to ensure patient safety and sample integrity:

• Patient Positioning: The patient is seated comfortably in a blood collection chair, and the arm is extended and supported.
• Site Selection and Cleansing: The phlebotomist identifies a suitable vein, typically the median cubital vein in the antecubital fossa (inner elbow). The skin over the selected vein is thoroughly cleansed with an antiseptic swab (70% isopropyl alcohol) and allowed to air dry to prevent contamination.
• Tourniquet Application: A sterile elastic tourniquet is applied a few inches above the venipuncture site to restrict venous blood flow, making the veins more prominent and easier to access.
• Venipuncture: A sterile, single-use needle attached to a vacuum collection tube is gently inserted into the vein. Patients may feel a brief, mild pinch or prick as the needle enters the skin.
• Sample Collection: The required volume of blood (typically 3 to 5 mL) is drawn into a red-top or gold-top serum separator tube (SST). Once the collection is complete, the tourniquet is released, and the needle is carefully withdrawn.
• Post-Puncture Care: Immediate pressure is applied to the puncture site with a sterile cotton ball or gauze pad to promote hemostasis and prevent hematoma formation. A small adhesive bandage is then applied over the site.
• Safety and Duration: The entire sample collection process takes less than five minutes. The patient is monitored briefly to ensure there is no dizziness or prolonged bleeding before they are cleared to leave.

When is a Typhidot IgM, IgG (Screening) Performed?

Prolonged Unexplained Fever

Physicians frequently request a Typhidot test when a patient presents with a high, prolonged fever (often characterized as a step-ladder pattern) that has lasted for more than three to four days without an obvious source. In endemic regions like Rawalpindi, enteric fever is a primary differential diagnosis for sustained pyrexia of unknown origin, and early screening helps rule in or rule out Salmonella typhi infection rapidly.

Gastrointestinal Symptoms and Abdominal Pain

Enteric fever significantly impacts the gastrointestinal tract. Patients exhibiting symptoms such as severe abdominal pain, tenderness, constipation (common in adults), or diarrhea (more common in children), accompanied by systemic features like headache, malaise, and extreme fatigue, are prime candidates for this screening. The test helps differentiate typhoid fever from other viral or bacterial gastroenteritis infections.

Suspected Exposure or Outbreak Involvement

During localized outbreaks of waterborne or foodborne illnesses, or when a patient has a history of close contact with a confirmed typhoid patient or chronic carrier, the Typhidot test is performed. It allows clinicians to screen symptomatic individuals quickly, facilitating prompt isolation, treatment, and public health reporting to limit further transmission.

Monitoring Treatment Response and Relapse

In patients previously diagnosed with typhoid fever who exhibit a recurrence of febrile symptoms after completing a course of antibiotics, the Typhidot test—specifically evaluating the IgG and IgM dynamics—can assist in assessing potential relapse. While IgG remains elevated for a long period, a re-elevation or persistence of high IgM titers can suggest an incomplete cure or reinfection.

Atypical Presentations of Systemic Infection

In some cases, typhoid fever presents atypically with hepatosplenomegaly (enlarged liver and spleen), dry cough, rose spots on the chest or abdomen, or mild delirium (typhoid state). When these clinical signs are observed during a physical examination, clinicians utilize the Typhidot screening to rapidly confirm the underlying bacterial etiology and prevent severe complications like intestinal perforation or hemorrhage.

What Does a Typhidot IgM, IgG (Screening) Detect?

The Typhidot IgM, IgG (Screening) test detects specific immunological markers produced by the body’s immune system in response to Salmonella typhi infection. The test identifies and distinguishes between the following clinical findings:

• Acute Infection (IgM Positive, IgG Negative): Indicates an early, active stage of typhoid fever, typically within the first week of symptom onset.
• Acute-on-Chronic or Late Acute Phase (IgM Positive, IgG Positive): Suggests an ongoing infection that has progressed beyond the initial days, or a reinfection in an individual with pre-existing antibodies.
• Past Exposure or Convalescent Phase (IgM Negative, IgG Positive): Indicates a previous infection, recovery from typhoid fever, or a late stage of convalescence where the active pathogen has been cleared but immunological memory persists.
• No Exposure (IgM Negative, IgG Negative): Suggests the absence of Salmonella typhi infection, or that the test was performed too early before detectable antibody levels could be produced by the immune system.
• Early Seroconversion: The transition phase where IgM is rising, allowing clinicians to track the immunological progression of the disease.
• Cross-Reactive Patterns: Helps distinguish typhoid from other febrile illnesses when interpreted alongside clinical symptoms.
• Antibody Persistence: Monitors the long-term presence of IgG antibodies in patients residing in endemic areas.

Turnaround Time and Report Access at Ayzal Lab

At Ayzal Lab, we understand that timely diagnostic results are crucial for effective clinical decision-making and patient peace of mind. The Typhidot IgM, IgG (Screening) test is processed using rapid immunochromatographic assays, allowing for an efficient turnaround time. Reports are typically finalized and verified by our consultant pathologist within a few hours of sample collection.

Patients can access their diagnostic reports conveniently. Ayzal Lab provides multiple digital avenues for report retrieval, including secure online portal access, direct delivery via WhatsApp, or SMS notifications with a download link. Physical copies of the reports can also be collected directly from the laboratory reception desk during working hours.

Typhidot IgM, IgG (Screening) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Salmonella typhi IgM Antibody	Negative (Non-reactive)	Positive (Reactive) – Indicates acute, active typhoid infection.
Salmonella typhi IgG Antibody	Negative (Non-reactive)	Positive (Reactive) – Indicates past infection, convalescent phase, or secondary response.
Clinical Correlation	No immunological evidence of typhoid	Active, recent, or past enteric fever requiring clinical management.
Sample Integrity	Adequate volume, non-hemolyzed	Hemolyzed or lipemic sample (may require recollection).
Control Line Validation	Visible control line (Valid test)	No control line visible (Invalid test, requires re-running).
Immune Status	Susceptible to infection	Presence of protective or memory antibodies (IgG positive).
Diagnostic Status	Enteric fever unlikely	Enteric fever highly probable; clinical correlation advised.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Ayzal Lab for Typhidot IgM, IgG (Screening)?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified pathologists and technologists dedicated to diagnostic excellence.
• Patient-Focused Care: We prioritize patient comfort, safety, and clear communication throughout the testing process.
• Quality Diagnostic Services: Ayzal Lab adheres to stringent internal and external quality control measures to ensure accurate results.
• Professional Reporting: All reports are verified by consultant pathologists, ensuring high clinical reliability.
• Modern Diagnostic Approach: We utilize advanced diagnostic kits and technologies for rapid and precise screening.
• Comfortable Environment: Our collection centers are designed to provide a clean, hygienic, and stress-free experience for patients.
• Convenient Location: Easily accessible facility in Rawalpindi, making it convenient for patients to visit for timely diagnostics.
• Commitment to Accurate Diagnosis: We are dedicated to providing dependable diagnostic insights that support effective patient treatment plans.